Search

Your search keyword '"Fabrizio Fabris"' showing total 440 results

Search Constraints

Start Over You searched for: Author "Fabrizio Fabris" Remove constraint Author: "Fabrizio Fabris"
440 results on '"Fabrizio Fabris"'

Search Results

1. β-Cyclodextrin Supramolecular Recognition of bis-Cationic Dithienylethenes

2. A resorcin[4]arene hexameric capsule as a supramolecular catalyst in elimination and isomerization reactions

3. Is Micellar Catalysis Green Chemistry?

4. PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes

5. Emergency Medicine Cases in Underwater and Hyperbaric Environments: The Use of in situ Simulation as a Learning Technique

6. EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA?

7. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study

8. Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial

10. Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected

11. Relapsing thrombotic thrombocytopenic purpura with low ADAMTS13 antigen levels: An indication for splenectomy?

12. Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study

13. Platelet-Derived Microparticles Bearing PF4 and Anti-GAGS Immunoglobulins in Patients with Sepsis

14. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders

15. Systemic Mastocytosis and Essential Thrombocythemia: Case Report and Literature Overview

16. Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia

18. Serum thrombopoietin and cMpl expression in thrombocytopenia of different etiologies

19. Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

20. A A386G biallelic GPIbα gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis

21. Novel point mutation in a leucine-rich repeat of the GPIbα chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families: the N41H variant

22. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

23. Recent metallosurfactants for sustainable catalysis in water

24. Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

25. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

26. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

27. Admission criteria for a cardiovascular short stay unit: a retrospective analysis on a pilot unit

28. Life-Saving Procedures Performed While Wearing CBRNe Personal Protective Equipment

29. A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome

30. Resorcin[4]arene Hexameric Capsule as a Supramolecular Catalyst in Elimination and Isomerization Reactions

32. Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry

33. Minimalistic β-sitosterol based designer surfactants for efficient cross-coupling in water

34. Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults

35. Nanoconfinement Effects of Micellar Media in Asymmetric Catalysis

36. A resorcin[4]arene hexameric capsule as a supramolecular catalyst in elimination and isomerization reactions

38. Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers

39. Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients

40. Clinical effect of CALR allele burden in patients with essential thrombocythemia

41. Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

42. Diketopyrrolopyrrole Bis‐Phosphonate Conjugate: A New Fluorescent Probe for In Vitro Bone Imaging

43. Functional bisphosphonate synthesis for the development of new anti-resorption bone drug candidates

44. EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA?

45. Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study

46. PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes

47. Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients

48. What changed in the Italian internal medicine and geriatric wards during the lockdown

49. Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge

50. Extremely Old Patients Hospitalized in Internal Medicine: What about Their Anemia?

Catalog

Books, media, physical & digital resources